Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Armitage

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
World Journal of Urology|December 20, 2017
Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weightingTobias Klatte, Kate Fife, Sarah J Welsh, et al.
Journal of Endourology|March 18, 2015
Hospital Volume Does Not Influence the Safety of Percutaneous Nephrolithotomy in England: A Population-Based Cohort StudyJohn M Withington, Susan C Charman, James N Armitage, et al.
British Journal of Cancer|June 11, 2009
High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK seriesH U Ahmed, E Zacharakis, T Dudderidge, et al.
Genome Research|April 26, 2000
Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mappingP A Lyons, N Armitage, F Argentina, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|April 8, 1998
Localization of two insulin-dependent diabetes (Idd) genes to the Idd10 region on mouse chromosome 3P L Podolin, P Denny, N Armitage, et al.
BJU International|July 17, 2024
'Case of the Month' from Addenbrooke's Hospital, Cambridge, UK: surgery after near complete response to combined immunotherapy and tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma with inferior vena cava tumour thrombusJames P Blackmur, James N Armitage, James O Jones, et al.
Nature Communications|November 10, 2025
Tumour sampling conditions perturb the metabolic landscape of clear cell renal cell carcinomaCissy Yong, Christina Schmidt, Ming Yang, et al.
BMC Medicine|October 4, 2019
The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohortTobias Klatte, Kevin M Gallagher, Luca Afferi, et al.
ERJ Open Research|June 1, 2022
Pulmonary function test and computed tomography features during follow-up after SARS, MERS and COVID-19: a systematic review and meta-analysisChristopher C Huntley, Ketan Patel, Shahnoor-E-Salam Bil Bushra, et al.
Immunity|August 10, 2000
The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137P A Lyons, W W Hancock, P Denny, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
World Journal of Urology|December 20, 2017
Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weightingTobias Klatte, Kate Fife, Sarah J Welsh, et al.
Journal of Endourology|March 18, 2015
Hospital Volume Does Not Influence the Safety of Percutaneous Nephrolithotomy in England: A Population-Based Cohort StudyJohn M Withington, Susan C Charman, James N Armitage, et al.
British Journal of Cancer|June 11, 2009
High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK seriesH U Ahmed, E Zacharakis, T Dudderidge, et al.
Genome Research|April 26, 2000
Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mappingP A Lyons, N Armitage, F Argentina, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|April 8, 1998
Localization of two insulin-dependent diabetes (Idd) genes to the Idd10 region on mouse chromosome 3P L Podolin, P Denny, N Armitage, et al.
BJU International|July 17, 2024
'Case of the Month' from Addenbrooke's Hospital, Cambridge, UK: surgery after near complete response to combined immunotherapy and tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma with inferior vena cava tumour thrombusJames P Blackmur, James N Armitage, James O Jones, et al.
Nature Communications|November 10, 2025
Tumour sampling conditions perturb the metabolic landscape of clear cell renal cell carcinomaCissy Yong, Christina Schmidt, Ming Yang, et al.
BMC Medicine|October 4, 2019
The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohortTobias Klatte, Kevin M Gallagher, Luca Afferi, et al.
ERJ Open Research|June 1, 2022
Pulmonary function test and computed tomography features during follow-up after SARS, MERS and COVID-19: a systematic review and meta-analysisChristopher C Huntley, Ketan Patel, Shahnoor-E-Salam Bil Bushra, et al.
Immunity|August 10, 2000
The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137P A Lyons, W W Hancock, P Denny, et al.
Pageof 7